364 related articles for article (PubMed ID: 26017274)
21. Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial.
Husted S; James S; Becker RC; Horrow J; Katus H; Storey RF; Cannon CP; Heras M; Lopes RD; Morais J; Mahaffey KW; Bach RG; Wojdyla D; Wallentin L;
Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):680-8. PubMed ID: 22991347
[TBL] [Abstract][Full Text] [Related]
22. Digoxin use after diagnosis of prostate cancer and survival: a population-based cohort study.
Karasneh RA; Murray LJ; Hughes CM; Cardwell CR
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1099-103. PubMed ID: 27146482
[TBL] [Abstract][Full Text] [Related]
23. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009
[TBL] [Abstract][Full Text] [Related]
24. Statin use after colorectal cancer diagnosis and survival: a population-based cohort study.
Cardwell CR; Hicks BM; Hughes C; Murray LJ
J Clin Oncol; 2014 Oct; 32(28):3177-83. PubMed ID: 25092779
[TBL] [Abstract][Full Text] [Related]
25. Association between benzodiazepine use and exacerbations and mortality in patients with asthma: a matched case-control and survival analysis using the United Kingdom Clinical Practice Research Datalink.
Nakafero G; Sanders RD; Nguyen-Van-Tam JS; Myles PR
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):793-802. PubMed ID: 26013409
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of preexisting diabetes mellitus in breast, colorectal, and prostate cancer.
Griffiths RI; Valderas JM; McFadden EC; Bankhead CR; Lavery BA; Khan NF; Stevens RJ; Keating NL
J Cancer Surviv; 2017 Oct; 11(5):604-613. PubMed ID: 28735467
[TBL] [Abstract][Full Text] [Related]
27. The use of aspirin and the risk of mortality in patients with prostate cancer.
Assayag J; Pollak MN; Azoulay L
J Urol; 2015 Apr; 193(4):1220-5. PubMed ID: 25463991
[TBL] [Abstract][Full Text] [Related]
28. Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers.
Cheng E; Soulos PR; Irwin ML; Cespedes Feliciano EM; Presley CJ; Fuchs CS; Meyerhardt JA; Gross CP
JAMA Netw Open; 2021 Dec; 4(12):e2139593. PubMed ID: 34919133
[TBL] [Abstract][Full Text] [Related]
29. Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis).
Valenti R; Marcucci R; Comito V; Marrani M; Cantini G; Migliorini A; Parodi G; Gensini GF; Abbate R; Antoniucci D
JACC Cardiovasc Interv; 2015 Oct; 8(12):1563-70. PubMed ID: 26386764
[TBL] [Abstract][Full Text] [Related]
30. Selecting antiplatelet therapy at the time of percutaneous intervention for an acute coronary syndrome: weighing the benefits and risks of prasugrel versus clopidogrel.
Salisbury AC; Wang K; Cohen DJ; Li Y; Jones PG; Spertus JA
Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):27-34. PubMed ID: 23212457
[TBL] [Abstract][Full Text] [Related]
31. Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study.
Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
Breast Cancer Res; 2018 Jan; 20(1):4. PubMed ID: 29351761
[TBL] [Abstract][Full Text] [Related]
32. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.
Vissers PA; Cardwell CR; van de Poll-Franse LV; Young IS; Pouwer F; Murray LJ
Breast Cancer Res Treat; 2015 Apr; 150(2):427-37. PubMed ID: 25762476
[TBL] [Abstract][Full Text] [Related]
33. Optimizing P2Y12 receptor inhibition in patients with acute coronary syndrome on the basis of platelet function testing: impact of prasugrel and high-dose clopidogrel.
Aradi D; Tornyos A; Pintér T; Vorobcsuk A; Kónyi A; Faluközy J; Veress G; Magyari B; Horváth IG; Komócsi A
J Am Coll Cardiol; 2014 Mar; 63(11):1061-70. PubMed ID: 24486281
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic intervals and its association with breast, prostate, lung and colorectal cancer survival in England: historical cohort study using the Clinical Practice Research Datalink.
Redaniel MT; Martin RM; Ridd MJ; Wade J; Jeffreys M
PLoS One; 2015; 10(5):e0126608. PubMed ID: 25933397
[TBL] [Abstract][Full Text] [Related]
35. Clopidogrel use and short-term mortality after peptic ulcer bleeding: a population-based cohort study.
Schmidt M; Riis AH; Christiansen CF; Lash TL; Sørensen HT
Am J Ther; 2013 Jan; 20(1):13-20. PubMed ID: 21326084
[TBL] [Abstract][Full Text] [Related]
36. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
Rosengart TK; Romeiser JL; White LJ; Fratello A; Fallon E; Senzel L; Shroyer AL
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
[TBL] [Abstract][Full Text] [Related]
37. Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events.
Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
Eur J Clin Invest; 2012 Mar; 42(3):266-74. PubMed ID: 21834799
[TBL] [Abstract][Full Text] [Related]
38. Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer.
Assayag J; Pollak MN; Azoulay L
Eur J Cancer; 2014 Nov; 50(16):2838-45. PubMed ID: 25204805
[TBL] [Abstract][Full Text] [Related]
39. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.
Ortolani P; Marino M; Marzocchi A; De Palma R; Branzi A
J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):783-9. PubMed ID: 21252697
[TBL] [Abstract][Full Text] [Related]
40. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
